Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Examining Longitudinal Markers of Bladder Cancer Recurrence Through a Semi-Autonomous Machine Learning System for Quantifying Specimen Atypia from Urine Cytology

View ORCID ProfileJoshua J. Levy, Natt Chan, Jonathan D. Marotti, Nathalie J. Rodrigues, A. Aziz O. Ismail, Darcy A. Kerr, Edward J. Gutmann, Ryan E. Glass, Caroline P. Dodge, Arief A. Suriawinata, View ORCID ProfileBrock Christensen, Xiaoying Liu, Louis J. Vaickus
doi: https://doi.org/10.1101/2023.03.02.23286716
Joshua J. Levy
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
2Department of Dermatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
3Department of Epidemiology, Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
4Program in Quantitative Biomedical Sciences, Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua J. Levy
  • For correspondence: joshua.j.levy{at}dartmouth.edu
Natt Chan
4Program in Quantitative Biomedical Sciences, Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan D. Marotti
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
5Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie J. Rodrigues
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Aziz O. Ismail
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
6White River Junction VA Medical Center, White River Junction, VT, 05009
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darcy A. Kerr
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
5Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward J. Gutmann
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
5Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
MD, AM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan E. Glass
7UPMC East, Pittsburg, PA, 15146
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline P. Dodge
8Cambridge Health Alliance, Cambridge, MA, 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arief A. Suriawinata
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
5Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brock Christensen
3Department of Epidemiology, Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
9Department of Molecular and Systems Biology, Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
10Department of Community and Family Medicine, Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brock Christensen
Xiaoying Liu
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
5Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis J. Vaickus
1Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03766
5Dartmouth College Geisel School of Medicine, Hanover, NH, 03756
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Urine cytology (UC) is generally considered the primary approach for screening for recurrence of bladder cancer. However, it is currently unclear how best to use cytological exams themselves for the assessment and early detection of recurrence, beyond identifying a positive finding which requires more invasive methods to confirm recurrence and decide on therapeutic options. As screening programs are frequent, and can be burdensome, finding quantitative means to reduce this burden for patients, cytopathologists and urologists is an important endeavor and can improve both the efficiency and reliability of findings. Additionally, identifying ways to risk-stratify patients is crucial for improving quality of life while reducing the risk of future recurrence or progression of the cancer. In this study, we leveraged a computational machine learning tool, AutoParis-X, to extract imaging features from UC exams longitudinally to study the predictive potential of urine cytology for assessing recurrence risk. This study examined how the significance of imaging predictors changes over time before and after surgery to determine which predictors and time periods are most relevant for assessing recurrence risk. Results indicate that imaging predictors extracted using AutoParis-X can predict recurrence as well or better than traditional cytological / histological assessments alone and that the predictiveness of these features is variable across time, with key differences in overall specimen atypia identified immediately before tumor recurrence. Further research will clarify how computational methods can be effectively utilized in high volume screening programs to improve recurrence detection and complement traditional modes of assessment.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

JL is supported by NIH subawards P20GM104416 and P20GM130454

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Dartmouth Hitchcock Health IRB of Dartmouth Health gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Conflict of Interest None to disclose.

  • Funding Sources JL is supported by NIH subawards P20GM104416 and P20GM130454

  • Precis This study used AutoParis-X, a machine learning tool, to extract imaging features from urine cytology exams to predict recurrence risk in bladder cancer patients. The results demonstrate that quantitative features of urine specimen atypia can predict recurrence as well or better than traditional cytological/histological assessments alone and can potentially complement traditional methods of assessment in screening programs pending further development and validation of computational methods which leverage multiple longitudinal cytology exams.

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 05, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Examining Longitudinal Markers of Bladder Cancer Recurrence Through a Semi-Autonomous Machine Learning System for Quantifying Specimen Atypia from Urine Cytology
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Examining Longitudinal Markers of Bladder Cancer Recurrence Through a Semi-Autonomous Machine Learning System for Quantifying Specimen Atypia from Urine Cytology
Joshua J. Levy, Natt Chan, Jonathan D. Marotti, Nathalie J. Rodrigues, A. Aziz O. Ismail, Darcy A. Kerr, Edward J. Gutmann, Ryan E. Glass, Caroline P. Dodge, Arief A. Suriawinata, Brock Christensen, Xiaoying Liu, Louis J. Vaickus
medRxiv 2023.03.02.23286716; doi: https://doi.org/10.1101/2023.03.02.23286716
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Examining Longitudinal Markers of Bladder Cancer Recurrence Through a Semi-Autonomous Machine Learning System for Quantifying Specimen Atypia from Urine Cytology
Joshua J. Levy, Natt Chan, Jonathan D. Marotti, Nathalie J. Rodrigues, A. Aziz O. Ismail, Darcy A. Kerr, Edward J. Gutmann, Ryan E. Glass, Caroline P. Dodge, Arief A. Suriawinata, Brock Christensen, Xiaoying Liu, Louis J. Vaickus
medRxiv 2023.03.02.23286716; doi: https://doi.org/10.1101/2023.03.02.23286716

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)